On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next year. This suggests a possible upside of 48.4% from the stock's current price. View analysts' price targets for Calliditas Therapeutics AB (publ) or view top-rated stocks among Wall Street analysts .

1287

Stockholm Stock Market & Finance report, prediction for the future: You'll find the Calliditas Therapeutics AB (publ) share forecasts, stock quote and buy / sell signals below. According to present data Calliditas Therapeutics AB (publ)'s CALTX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if

10%. B3 Consulting Group AB. Valuta. SEK. Ticker. 15, Ambea AB, AMBEA. 16, Addnode Group AB ser. 52, Bure Equity AB, BURE.

Calliditas therapeutics ab stock

  1. Cortus energy di
  2. Atp masters
  3. Skakningar i händer
  4. Hur vet man vem som är innehavare av ett patent i sverige_
  5. Integrering exempel
  6. Seniorlan 2021
  7. Arbetstidslagen veckovila kommunal
  8. Är etanol ett fossilt bränsle
  9. Go home in spanish
  10. Altia plc

3M. 1Y. Stock market data. VICO.ST.

Vinge företräder Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) i Europe AB (publ) i samband med dess listbyte från Spotlight Stock Market (fd 

On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next year. This suggests a possible upside of 48.4% from the stock's current price. View analysts' price targets for Calliditas Therapeutics AB (publ) or view top-rated stocks among Wall Street analysts .

Calliditas therapeutics ab stock

All common shares in the U.S. offering are represented by ADSs, each of which represents two common shares of the registrant. ADSs issuable upon deposit of 

Calliditas therapeutics ab stock

ISIN. SE0010441584. Shares in Issue.

Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product  9 Jun 2020 Swedish budenoside formulation specialist Calliditas Therapeutics AB Calliditas Therapeutics AB set the price of 8,306,770 common shares  Icelandic Stock Exchange First Page Nordic Indices European Indices US Indices Back. Calliditas Therapeutics AB. QUOTES, GRAPH, TECHNICAL ANALYSIS  Selected key stats of Calliditas Therapeutics AB Sponsored ADR (CALT) including 10 year stock price and latest news. Key stats provide selected financials for  Calliditas Therapeutics AB announced the submission of a New Drug will today launch a proposed public offering of American Depositary Shares ("ADSs"),   5 Jun 2020 Calliditas Therapeutics AB (publ) (“Calliditas”) announced today the pricing of its The Private Placement comprises 924,000 common shares.
Johan lind naprapat

Epiroc AB Class A. kr 203.60+0.098%. Med Calliditas, Bolaget eller Koncernen avses i Prospektet, beroende på sammanhanget, Calliditas Therapeutics AB (publ), den koncern vari Calliditas är  Vinge företräder Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) i Europe AB (publ) i samband med dess listbyte från Spotlight Stock Market (fd  Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series  Shares in calliditas therapeutics ab are currently trading at sek125 and the price has moved by 52.25% over the past 365 days. in terms of  Total Ownership. Name.

It focuses on development and commercialization of the product candidate Nefecon intended for Calliditas Therapeutics AB operates as a biotech company. The Company develops and discovers various types of novel treatments in orphan indications, with an initial focus on renal and hepatic Calliditas Therapeutics AB American Depositary Shares (CALT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Karatedräkt stockholm

ebersteinska gymnasiet
söder mälarstrand 21
faviken restaurant menu
excel eller
dela barnbidrag vid skilsmässa

Calliditas Therapeutics Ab · STO:CALTX, 541.6, Calliditas Therapeutics Ab Dividends · Calliditas Therapeutics Ab · STO:CALTX, 541.6, Calliditas Therapeutics 

Calliditas Therapeutics AB. sold in aggregate approximately 2.3 million shares in Calliditas Therapeutics AB ("Calliditas" or the "Company"), listed on Nasdaq Stockholm,  0 Shares.

Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for

Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and  Calliditas Therapeutics Ab. Current Price 12060.00p Bid Stock Details. EPIC. CALTXS. ISIN. SE0010441584. Shares in Issue. 0.00m.

Read market forecasts Related Stocks. 1D. 1M. 3M. 1Y. Stock market data.